Popular
BlogNEW
CompaniesNEW
Finance
Technology
Banking
Information Technology
Oil and Energy
Internet
Mining and Metals
Communications
Real Estate
Biotechnology
Automotive
Medical
Retail
Energy
Investor Presentaiton slide image

Investor Presentaiton

Highly Diversified Revenue Base Emerging Markets 19% Western Europe & Other Markets # 11% India Branded Formulations FY18 Sales Rs 261 billion 31% © Sun Pharmaceutical Industries Limited. All Rights Reserved. API & Others 5% US Formulations 34% SUN PHARMA # Includes Western Europe, Canada, Japan, Australia, New Zealand and other markets. 9
View entire presentation

Product

HomeSearchAccount

Categories

Finance PresentationsTechnology PresentationsBanking PresentationsInformation Technology PresentationsOil and Energy PresentationsInternet PresentationsMining and Metals PresentationsCommunications PresentationsReal Estate PresentationsBiotechnology PresentationsAutomotive PresentationsMedical PresentationsRetail PresentationsEnergy Presentations

Company

InsightsContactSupport

Legal

Terms of ServicePrivacy Policy

Connect

TwitterLinkedInInstagramYouTube